The Tri-Institutional MD-PhD Program (Tri-I) is a joint undertaking between Weill Cornell Medicine, The Rockefeller University, and Memorial Sloan Kettering Cancer Center. Trainees complete their MD degree at Weill Cornell Medical College, and PhD training at one of the three participating graduate schools: Weill Cornell Graduate School of Medical Sciences; the David Rockefeller Graduate Program in Bioscience; or the Louis V. Gerstner Jr. Graduate School of Biomedical Sciences. Tri-I guides students through a rigorous course of study that offers flexibility and unfettered access to experienced mentors in leading laboratories. An integrated curriculum reinforces the students’ identities as clinician-scientists; equally well-prepared to work in the laboratory and at the bedside, Tri-I graduates bridge the gap between clinical medicine and laboratory research. 

Learn more about the Tri-Institutional MD-PhD Program by watching the short video below.

Ross Levine, MD, the Laurence Joseph Dineen Chair in Leukemia Research at Memorial Sloan Kettering Cancer Center and Professor at Weill Cornell Medical College, has been named as the 2018 William Dameshek Prize winner by The American Society of Hematology. The William Dameshek Prize is awarded to an early- or mid-career hematologist who has made a recent outstanding contribution to the field of hematology. 
The National Academy of Medicine has named a Tri-Institutional MD-PhD Program alumnus, Sandeep Kishore, MD, PhD, MSc, and a current Tri-Institutional faculty member, Sohail Tavazoie, MD, PhD, as 2018-2019 Emerging Leaders in Health and Medicine.